TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
Active, not recruiting · NCT04294264 · Registry updated 2024-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 2 | 2024-11-18 | NCT04294264 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| Rutgers, The State University of New Jersey | 154 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rutgers Cancer Institute of New Jersey | New Brunswick | United States | 223 |
| RWJBarnabas Health - Community Medical Center | Toms River | United States | 9 |
| RWJBarnabas Health - Monmouth Medical Center | Long Branch | United States | 7 |
| RWJBarnabas Health - Monmouth Medical Center Southern Campus | Lakewood | United States | 8 |
| Saint Barnabas Medical Center | Livingston | United States | 31 |
| Trinitas Hospital and Comprehensive Cancer Center | Elizabeth | United States | 5 |